Colossal Biosciences News and Activities
Presence
Colossal Biosciences develops biotechnology for species restoration and conservation. Its products and services include genetic engineering, reproductive tools, and animal health research for conservation groups, research partners, and government organizations.
Colossal Biosciences products and services overview:
- Genetic engineering
- Species restoration
- Conservation tools
- Reproductive technology
- Animal health research
Revenue: ~$0 million
Employees: 170
Headquarters: Dallas, United States (USA)
Colossal Biosciences is one of the...
Acquisition, funding and merger involving Colossal Biosciences.
- Colossal Biosciences has just announced a $120 Million fundraising (posted on September 23 2025).
- Colossal Biosciences has just announced a $200 Million fundraising (posted on January 16 2025).
Executives
View the org chart displaying its 16 main executives
Most searched biographies at Colossal Biosciences
Create your alert
to follow the executive moves at Colossal Biosciences.
Biotechnology
Colossal Biosciences has 2,413 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).
Popular M&A news in Biotechnology
- Ollin Biosciences has just announced a $330 Million fundraising (posted on June 24 2026).
- RQ Biotechnology has just announced a $86 Million fundraising (posted on June 24 2026).
- Boundless Bio has filed its IPO. Its stock ticker will be AATD. (posted on June 23 2026).
Popular contacts in Biotechnology
News
Press releases by Colossal Biosciences
- Dodo De-Extinction Moves Forward at Colossal - Colossal
- How dodo de-extinction is helping rescue the extraordinary pink pigeon
- Learn how we are getting to a better world.
- Learn how we are getting to a better world.
Social media about Colossal Biosciences
- Colossal Biosciences on Wikipedia, Google News & Yahoo Finance
- Colossal Biosciences on LinkedIn, X (Twitter) & YouTube
